Foster 100/6 mikrograma po potisku, stlačeni inhalat, otopina
| Name | Foster 100/6 mikrograma po potisku, stlačeni inhalat, otopina |
|---|---|
| Marketing Authorisation Number | HR-H-229073870 |
| Active Substance | beklometazondipropionat formoterolfumarat dihidrat |
| Composition | Jedna odmjerena doza (potiskom preko ventila) sadrži 100 mikrograma beklometazondipropionata i 6 mikrograma formoterolfumarat dihidrata. To odgovara isporučenoj dozi (preko nastavka za usta) od 84,6 mikrograma beklometazondipropionata i 5,0 mikrograma formoterolfumarat dihidrata |
| Pharmaceutical Form | stlačeni inhalat, otopina |
| Manufacturer | Chiesi Pharmaceuticals GmbH, Beč, Austrija Chiesi Farmaceutici S.p.A., Parma, Italija |
| Marketing Authorisation Holder | Chiesi Pharmaceuticals GmbH, Gonzagagasse 16/16, Beč, Austrija |
| Marketing Authorisation Date | 26.02.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/74 |
| Registration Number | 381-12-01/30-19-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R03AK08 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
